Evidence map›Paper›PMID 24356332›Full record

ArticleNeonatology2014

Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.

Holly J Engelstad, Robert D Roghair, Chadi A Calarge, Tarah T Colaizy, Scott Stuart, Sarah E Haskell

Open access · greenAbstract read
In one paragraph

Article in Neonatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Selective serotonin reuptake inhibitor exposure constricts the mouse ductus arteriosus in utero.American journal of physiology. Heart and circulatory physiology · 2016
    Article
  11. MTHFR genetic polymorphism increases the risk of preterm delivery.International journal of clinical and experimental pathology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Holly J EngelstadDepartment of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Robert D Roghair
Chadi A Calarge
Tarah T Colaizy
Scott Stuart
Sarah E Haskell
Pediatrics and Genetics · USUniversity of Iowa · US

Funding

Molecular and Cellular Research to Advance Childhood HealthK12HD027748 · NICHD · UNIVERSITY OF IOWA · PI ALEXANDER G BASSUK · 2002 to 2026
$9.2M
Neonatal Growth and the Neurodevelopmental Origins of HypertensionR01HL102659 · NHLBI · UNIVERSITY OF IOWA · PI ROGHAIR, ROBERT D · 2010 to 2014
$1.8M
NHLBI NIH HHS R01 HL102659NICHD NIH HHS K12 HD027748
6 · The paper itself

Abstract

backgroundSelective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed psychotropics for major depressive disorder during pregnancy and are used in up to 6.2% of pregnancies.

objectiveTo compare the perinatal outcomes of pregnancies complicated by maternal depression with or without SSRI therapy versus nondepressed pregnancies.

methodsInternational Classification of Diseases (ICD)-9 codes for depression were identified among women who delivered at the University of Iowa from April 2009 to March 2011. Data were extracted from linked maternal-neonatal records for all charts with an ICD-9 code for depression and an equal number of women without ICD-9 codes for depression.

resultsOf the 3,695 women who delivered between 2009 and 2011, 238 had an ICD-9 code for depression. Sixteen women had depression listed in their records but did not have an ICD-9 code for depression. Their data were combined with those of the women with ICD-9 codes for depression, and it was found that 126 women (50%) in this combined depression cohort received an SSRI. Women with depression had increased alcohol and tobacco use, BMI and premature delivery rates (p < 0.01). Maternal depression was associated with an increased frequency of neonatal intensive care unit (NICU) admission (p < 0.001). In addition to depression, maternal SSRI use, obesity and smoking were univariate predictors of NICU admission.

conclusionsAmong women with depression, the use of an SSRI was not associated with significant differences in any of the measured maternal or neonatal parameters, but further studies are needed to evaluate the specific effects of SSRI exposure in early or late gestation. Despite SSRI utilization, women with depression continue to have increased risks during pregnancy.

Indexed as

AdultDepressive DisorderFemaleHumansInfant, NewbornInfant, Newborn, DiseasesIntensive Care Units, NeonatalPatient AdmissionPregnancyPregnancy ComplicationsPregnancy OutcomePrenatal Exposure Delayed EffectsPrognosisSelective Serotonin Reuptake InhibitorsSeverity of Illness IndexSelective Serotonin Reuptake Inhibitors

Identifiers

PMID24356332
PMCPMC4054700
OpenAlexW1972611342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.